Responsible leadership is integral to who we are and how we innovate.
“Roivant’s corporate responsibility commitments are fundamental to realizing our bold vision to accelerate the development and commercialization of medicines that matter for patients. They represent our focus on the long-term impact and value we intend to create for our patients, our shareholders, and our society.”
– Matt Gline, CEO, Roivant Sciences
01
Accelerating Transformation Through Agility and Disciplined Governance
02
Empowering Diverse People and Pathways
03
Investing in Health Equity and Our Communities
04
Intentional Environmental Stewardship
01. Accelerating Transformation Through Agility and Disciplined Governance
We designed the Vant model to scale responsibly and unlock strategic advantages.
Governance advantages enabled by the Vant model:
Creating nimble, entrepreneurial Vants
Vants operate similarly to independent biotechnology companies where each management team is focused on its respective mission and is economically incentivized to maximize value through Vant-specific equity grants. Each of our Vant teams is built with deep relevant expertise to ensure successful execution of its particular development strategy. The Vant model is designed to facilitate rapid decision making and calculated risk taking, by empowering, aligning and incentivizing Vant teams around the outcomes of their specific product candidates.
Allocating capital to maximize R&D efficiency
We apply an objective, rigorous decision-making framework across the drug development process designed to ensure resources and capital are continuously directed towards programs we believe have a higher probability of success and away from those that fail to meet our internal hurdles. We centralize capital allocation decisions at the Roivant level, while distributing operational decisions to the Vants, allowing us to strategically deploy capital in high growth areas, regardless of potentially competing operational priorities.
Maintaining a diversified pipeline with various risk profiles
We have built a broad and differentiated pipeline that includes several drug candidates across different therapeutic areas, phases of development, modalities and geographies. This approach limits our exposure to concentrated scientific and biological risks and allows us to pursue multiple innovative hypotheses across our portfolio as we seek to develop therapies for patient populations with high unmet need.
FDA approvals since founding
positive Phase 3 trials since 2019
Wholly owned commercial launch
Overseeing ESG
Board oversight of our Environmental, Social and Governance (“ESG”) efforts has been delegated to the Nominating and Governance Committee, whose charter includes evaluating and overseeing our ESG principles, initiatives and risks. Internally, ESG is managed by the ID&C Committee led by our Chief Operating Officer, Roivant Platforms and includes key members from our Operations, Legal, Finance and People teams. The ID&C Committee aims to sustain a dynamic workplace where belonging and inclusion is experience through service, community engagement, and collective impact.
Upholding Integrity, Ethics and Compliance
Roivant’s Board of Directors establishes company standards for corporate governance and compliance, which are operationalized by our business and legal teams. The following policy documents can be requested via the links below.
Adhering to Healthcare Laws and Regulations
As we develop transformative medicines, we are governed by healthcare laws and regulations. Roivant’s policies outline our compliance principles and expectations and can be requested via the links below.
Safeguarding Data
We rely on advanced data technologies to power our Vants. Our policies are intended to protect this data and can be requested via the links below.
02. Empowering Diverse People and Pathways
Roivant became Great Place to Work® certified in 2023.
Roivant made Fast Company’s 2024 list of the 100 Best Workplaces for Innovators as well as a spot on the 2024 Biotech list.
Human Capital Objectives
Our human capital objectives include sourcing, recruiting, retaining, and developing our existing and future employees. We believe we can achieve our human capital objectives by implementing the following approaches:
Strategic recruitment and development efforts
Hire high-caliber talent across all levels using both a dedicated in-house talent acquisition team and top-tier executive search firms
Recruit multidisciplinary talent from a broad range of industries, including biopharmaceuticals, financial services, technology and consulting
Unlock unique career progression across Roivant and Vants through “Vant mobility” and offer unparalleled leadership opportunities for employees through the Vant model
Investment in early career development and diversity
Invest in early career development through a number of important initiatives:
- A robust Roivant Analyst (“RA”) program, hiring recent college graduates from top private and public institutions
- Partnership with Life Science Cares’ Project Onramp to broaden access to early career opportunities in the life sciences
- Partnership with Girls Who Invest to help attract and support women investors
Competitive incentives and benchmarking
Offer highly competitive short- and long-term incentives through both Roivant and Vant share-based compensation programs and meaningful performance-based cash bonuses
Undertake rigorous benchmarking analyses in partnership with third parties to ensure competitive compensation practices and conduct annual pay equity analyses to detect, analyze and remediate any compensation disparities where appropriate
Offer a professional development stipend to each employee for use towards individual growth and development
Embracing Diversity
At Roivant, our goal is to improve human health by rapidly discovering, developing and delivering innovative medicines and technologies to all patients. Our success is predicated on attracting and retaining top talent, generating new ideas and promoting an open and collaborative culture.
We embrace diversity across all dimensions and levels of the organization, and we strive to ensure every employee is supported in reaching their full potential. We seek to hire motivated people with diverse backgrounds, identities, experiences, and skillsets. As of June 30, 2023, among full-time employees at Roivant and its consolidated subsidiaries, 53% were female and 31% identified as being from diverse racial and ethnic groups. Among Roivant’s board members, two out of eight directors are female and one director identifies as being from a diverse racial or ethnic group. We are committed to fostering an inclusive culture where all employees are valued, respected, and empowered to create value for patients.
Inclusion, Diversity, and Community (ID&C) Committee
Our ID&C committee is led by our Chief Operating Officer, Roivant Platforms, and is comprised of a diverse set of employees across Roivant. Committee members actively promote employee engagement and education initiatives, including company-wide trainings and guest speakers. Committee members also provide support to our employee resource groups (“ERGs”) and identify and implement community engagement initiatives, including our Annual Day of Service.
Facilitating Inclusion and Belonging through Employee Resource Groups (ERG)s
Women@Roivant
Support and develop the next generation of Roivant’s women leaders while building, engaging, and strengthening internal and external communities.
Asian@Roivant
Aims to provide community and leadership development for our Asian American and Pacific Islander employees.
BIPOC
Promote and celebrate Roivant’s cultural diversity, provide a supportive community and serve as a haven of belonging for Roivant's BIPOC community.
ROI-GBIV
Foster education, personal and career growth, idea sharing, networking, awareness of LGBTQ+ perspectives, and enhancement of diversity recruitment and retention efforts.
Fostering a Transparent, Connected and Growth-Oriented Culture
CEO all-team newsletters
Small group roundtables with CEO to encourage feedback
Quarterly townhalls and all-hands in-office weeks to facilitate cultural connectivity
Biannual employee engagement survey
Learning and development platform with company wide courses and self-directed learning
Tuition reimbursement and annual professional development stipend
ERG events focused on education and development
Recruiting and Retaining the Brightest Minds
We recruit talent from various industries, including biopharmaceuticals, financial services, technology and consulting and emphasize cultural alignment and diversity in skillsets and perspectives.
Roivant partners with top-tier executive search firms to identify and recruit high-caliber talent. In parallel, Roivant’s in-house talent acquisition team provides bespoke sourcing and high-touch end-to-end recruitment processes across Roivant and the broader Roivant portfolio to meet our unique hiring needs and vision for disrupting the healthcare industry.
Roivant’s workforce has geographic as well as project flexibility to attract the best talent and support retention.
For example, we encourage our R&D team to work across multiple therapeutic areas and modalities, fostering a culture of continuous learning and professional growth. This cross-disciplinary approach benefits our research outcomes and helps employees to expand their skills and stay mobile within our organization.
Offering Highly Competitive Short- and Long-Term Incentives
We offer competitive salaries, regularly review compensation practices and analyze the equity of compensation decisions for all employees. Our compensation practices include an annual year-end cash bonus to reward employees for their contribution to Roivant’s success. We also provide employee ownership by offering participation in equity programs, including stock options and/or restricted stock unit grants, and an employee stock purchase program.
03. Intentional Environmental Stewardship
We are mindful about minimizing our environmental footprint. At RSI, for example, our efforts to minimize our environment impact include the following:
Implementation of an Environmental Management System policy
Partnership with third-party vendor to repurpose and recycle our electronics and IT materials and related toxic waste
Installation of water refill stations, reducing reliance on bottled water
Utilization of waste management services, recycling and energy/electricity savings in our offices
Additional Information
Visit our ‘For Investors’ site to see our SEC filings and corporate governance documents